JP2012532185A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532185A5 JP2012532185A5 JP2012518956A JP2012518956A JP2012532185A5 JP 2012532185 A5 JP2012532185 A5 JP 2012532185A5 JP 2012518956 A JP2012518956 A JP 2012518956A JP 2012518956 A JP2012518956 A JP 2012518956A JP 2012532185 A5 JP2012532185 A5 JP 2012532185A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate
- therapeutic agent
- asparaginase
- peg
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22332009P | 2009-07-06 | 2009-07-06 | |
| US61/223,320 | 2009-07-06 | ||
| EPPCT/EP2010/054156 | 2010-03-30 | ||
| PCT/EP2010/054156 WO2011003633A1 (en) | 2009-07-06 | 2010-03-30 | Pegylated l-asparaginase |
| PCT/EP2010/059599 WO2011003886A1 (en) | 2009-07-06 | 2010-07-06 | Pegylated l-asparaginase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532185A JP2012532185A (ja) | 2012-12-13 |
| JP2012532185A5 true JP2012532185A5 (enExample) | 2013-08-22 |
| JP6014956B2 JP6014956B2 (ja) | 2016-10-26 |
Family
ID=42232655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012518956A Active JP6014956B2 (ja) | 2009-07-06 | 2010-07-06 | ペグ化されたｌ−アスパラギナーゼ |
Country Status (25)
| Country | Link |
|---|---|
| US (6) | US20120100121A1 (enExample) |
| JP (1) | JP6014956B2 (enExample) |
| KR (1) | KR101731999B1 (enExample) |
| CN (1) | CN102573917B (enExample) |
| AU (1) | AU2010270294B2 (enExample) |
| BR (1) | BR112012000367A2 (enExample) |
| CA (1) | CA2767149C (enExample) |
| CO (1) | CO6612174A2 (enExample) |
| DK (1) | DK2451486T4 (enExample) |
| EA (1) | EA021168B1 (enExample) |
| ES (1) | ES2636476T5 (enExample) |
| FI (1) | FI2451486T4 (enExample) |
| HU (1) | HUE035771T2 (enExample) |
| IL (1) | IL217392A (enExample) |
| IN (1) | IN2012DN00958A (enExample) |
| LT (1) | LT2451486T (enExample) |
| MA (1) | MA33503B1 (enExample) |
| MX (1) | MX2012000424A (enExample) |
| MY (1) | MY180758A (enExample) |
| NZ (1) | NZ597912A (enExample) |
| PE (2) | PE20120501A1 (enExample) |
| PT (1) | PT2451486T (enExample) |
| SG (1) | SG176984A1 (enExample) |
| UA (1) | UA104634C2 (enExample) |
| WO (2) | WO2011003633A1 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE531779C2 (sv) * | 2007-11-26 | 2009-08-04 | Promimic Ab | Framställning av kalciumfosfatpartiklar i nanostorlek som pulver eller beläggning via bifunktionella prekursorer |
| WO2011003633A1 (en) | 2009-07-06 | 2011-01-13 | Alize Pharma Ii | Pegylated l-asparaginase |
| WO2015033344A1 (en) | 2013-09-05 | 2015-03-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs) |
| US20160213759A1 (en) * | 2013-09-10 | 2016-07-28 | Board Of Regents, The University Of Texas System | Therapeutic asparaginases |
| CN104046600B (zh) * | 2013-12-30 | 2019-04-05 | 江苏众红生物工程创药研究院有限公司 | 多臂聚乙二醇修饰剂的新用途及其在修饰门冬酰胺酶中的应用 |
| BR102014000585B1 (pt) | 2014-01-10 | 2021-01-12 | Coppe/Ufrj-Instituto Alberto Luiz Coimbra De Pós-Graduação | l-asparaginase recombinante de zymomonas |
| US9808011B2 (en) | 2014-12-15 | 2017-11-07 | Biovectra Inc. | Pentacyclic triterpene compounds and uses thereof |
| CN105802948B (zh) | 2014-12-29 | 2020-06-09 | 江苏众红生物工程创药研究院有限公司 | 聚乙二醇定点修饰的门冬酰胺酶及其制备方法与应用 |
| ES2839212T3 (es) | 2015-09-29 | 2021-07-05 | Inst Nat Sante Rech Med | Métodos para determinar el estado metabólico de linfomas B |
| US10821160B2 (en) | 2016-03-01 | 2020-11-03 | The Board Of Trustees Of The University Of Illinois | L-asparaginase variants and fusion proteins with reduced L-glutaminase activity and enhanced stability |
| EP3463308B2 (en) * | 2016-06-01 | 2026-01-07 | Servier IP UK Limited | Formulations of polyalkylene oxide-asparaginase and methods of making and using the same |
| UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
| US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12478604B1 (en) | 2016-07-22 | 2025-11-25 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12186296B1 (en) | 2016-07-22 | 2025-01-07 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| WO2018085493A1 (en) * | 2016-11-04 | 2018-05-11 | Georgia State University Research Foundation, Inc. | Endotoxin free asparaginase |
| KR102727396B1 (ko) * | 2017-06-21 | 2024-11-08 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 변형된 l-아스파라기나아제 |
| US10174302B1 (en) | 2017-06-21 | 2019-01-08 | Xl-Protein Gmbh | Modified L-asparaginase |
| EP3418383A1 (en) * | 2017-06-21 | 2018-12-26 | XL-protein GmbH | Modified l-asparaginase |
| US10662433B2 (en) | 2017-10-27 | 2020-05-26 | Pfenex Inc. | Method for production of recombinant E. coli asparaginase |
| WO2019083793A1 (en) * | 2017-10-27 | 2019-05-02 | Pfenex Inc. | Method for production of recombinant erwinia asparaginase |
| BR112020010976A2 (pt) * | 2017-11-30 | 2020-11-17 | Jazz Pharmaceuticals Ireland Limited | métodos de tratamento com asparaginase |
| CN112261949B (zh) * | 2018-04-19 | 2025-05-06 | 伊兰科美国公司 | 用于医疗用途的变体天冬酰胺酶多肽 |
| US20210299233A1 (en) | 2018-07-12 | 2021-09-30 | The Children's Medical Center Corporation | Method for treating cancer |
| JP2022514942A (ja) * | 2018-12-24 | 2022-02-16 | ジェノバ バイオファーマスーティカルズ リミテッド | ペグアスパラガーゼの凍結乾燥組成物 |
| US11400065B2 (en) | 2019-03-01 | 2022-08-02 | Flamel Ireland Limited | Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state |
| GB201912020D0 (en) * | 2019-08-21 | 2019-10-02 | Porton Biopharma Ltd | Therapeutic Conjugate |
| AU2020371963A1 (en) * | 2019-10-25 | 2022-05-26 | Jazz Pharmaceuticals Ireland Ltd. | Recombinant L-asparaginase |
| KR102269634B1 (ko) * | 2019-10-31 | 2021-06-25 | 대상 주식회사 | ansB 유전자 불활성화에 의해 아미노산 생산능력이 향상된 균주 |
| KR20230125179A (ko) | 2020-12-23 | 2023-08-29 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 전하-차폐 융합 단백질의 정제 방법 |
| CN114854729B (zh) * | 2021-02-03 | 2025-09-02 | 重庆派金生物科技有限公司 | 定向化学偶联门冬酰胺酶突变体及其制备方法和应用 |
| US20220313798A1 (en) | 2021-03-30 | 2022-10-06 | Jazz Pharmaceuticals Ireland Ltd. | Dosing of recombinant l-asparaginase |
| US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
| US20260000740A1 (en) | 2022-07-04 | 2026-01-01 | Institut National de la Santé et de la Recherche Médicale | Use of a l-asparaginase in combination with a ferroptosis inducer for the treatment of extranodal natural killer/t-cell lymphoma |
| WO2024015529A2 (en) | 2022-07-14 | 2024-01-18 | Jazz Pharmaceuticals Ireland Ltd. | Combination therapies involving l-asparaginase |
| WO2024211977A1 (pt) * | 2023-04-12 | 2024-10-17 | Biobreyer Pesquisa E Desenvolvimento Científico Ltda | Processo de peguilação sítio específica de lasparaginase contendo cisteínas de superfície, produto obtido por processo e uso |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
| US5286637A (en) | 1989-08-07 | 1994-02-15 | Debiopharm, S.A. | Biologically active drug polymer derivatives and method for preparing same |
| US5766897A (en) | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| GB9017002D0 (en) | 1990-08-02 | 1990-09-19 | Health Lab Service Board | Improved method for the purification of erwina l-asparaginase |
| US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| US5359030A (en) | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5681811A (en) | 1993-05-10 | 1997-10-28 | Protein Delivery, Inc. | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| US5776746A (en) | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
| US6309633B1 (en) | 1999-06-19 | 2001-10-30 | Nobex Corporation | Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same |
| US20020065397A1 (en) | 2000-10-12 | 2002-05-30 | Joseph Roberts | Protecting therapeutic compositions from host-mediated inactivation |
| US6913915B2 (en) * | 2001-08-02 | 2005-07-05 | Phoenix Pharmacologics, Inc. | PEG-modified uricase |
| AU2002332371A1 (en) * | 2001-08-22 | 2003-03-10 | Gosudarstvennoe Uchrezhdenie Nauchno-Issledovatelsky Institut Biomeditsinskoy Khimii Im. Orekhovicha | Recombinant l-asparaginase less thanigreater thanerwinia caratovoraless than/igreater than |
| JP2006523211A (ja) | 2003-03-14 | 2006-10-12 | ネオス テクノロジーズ インコーポレイテッド | 分岐水溶性ポリマーとその複合物 |
| WO2007103290A2 (en) | 2006-03-03 | 2007-09-13 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Materials and methods directed to asparagine synthetase and asparaginase therapies |
| JP5163491B2 (ja) | 2006-04-21 | 2013-03-13 | コニカミノルタホールディングス株式会社 | ガスバリアフィルムの製造方法、有機エレクトロルミネッセンス用樹脂基材、それを用いた有機エレクトロルミネッセンス素子 |
| EP2137307B1 (en) * | 2007-03-09 | 2014-07-30 | Novozymes A/S | Thermostable asparaginases |
| WO2011003633A1 (en) | 2009-07-06 | 2011-01-13 | Alize Pharma Ii | Pegylated l-asparaginase |
| WO2017106630A1 (en) | 2015-12-18 | 2017-06-22 | The General Hospital Corporation | Polyacetal polymers, conjugates, particles and uses thereof |
-
2010
- 2010-03-30 WO PCT/EP2010/054156 patent/WO2011003633A1/en not_active Ceased
- 2010-07-06 NZ NZ597912A patent/NZ597912A/en unknown
- 2010-07-06 AU AU2010270294A patent/AU2010270294B2/en active Active
- 2010-07-06 DK DK10730170.7T patent/DK2451486T4/da active
- 2010-07-06 ES ES10730170T patent/ES2636476T5/es active Active
- 2010-07-06 MA MA34598A patent/MA33503B1/fr unknown
- 2010-07-06 FI FIEP10730170.7T patent/FI2451486T4/fi active
- 2010-07-06 LT LTEP10730170.7T patent/LT2451486T/lt unknown
- 2010-07-06 MX MX2012000424A patent/MX2012000424A/es active IP Right Grant
- 2010-07-06 KR KR1020127003202A patent/KR101731999B1/ko active Active
- 2010-07-06 MY MYPI2012000054A patent/MY180758A/en unknown
- 2010-07-06 BR BR112012000367A patent/BR112012000367A2/pt not_active Application Discontinuation
- 2010-07-06 CN CN201080030392.6A patent/CN102573917B/zh active Active
- 2010-07-06 EA EA201270134A patent/EA021168B1/ru not_active IP Right Cessation
- 2010-07-06 WO PCT/EP2010/059599 patent/WO2011003886A1/en not_active Ceased
- 2010-07-06 PE PE2012000023A patent/PE20120501A1/es not_active Application Discontinuation
- 2010-07-06 SG SG2011096013A patent/SG176984A1/en unknown
- 2010-07-06 US US13/382,276 patent/US20120100121A1/en not_active Abandoned
- 2010-07-06 PE PE2016001555A patent/PE20161325A1/es unknown
- 2010-07-06 UA UAA201201135A patent/UA104634C2/ru unknown
- 2010-07-06 HU HUE10730170A patent/HUE035771T2/en unknown
- 2010-07-06 JP JP2012518956A patent/JP6014956B2/ja active Active
- 2010-07-06 CA CA2767149A patent/CA2767149C/en active Active
- 2010-07-06 PT PT107301707T patent/PT2451486T/pt unknown
-
2012
- 2012-01-05 IL IL217392A patent/IL217392A/en active IP Right Grant
- 2012-02-02 IN IN958DEN2012 patent/IN2012DN00958A/en unknown
- 2012-02-06 CO CO12020409A patent/CO6612174A2/es unknown
-
2015
- 2015-08-05 US US14/819,305 patent/US9920311B2/en not_active Ceased
-
2018
- 2018-02-01 US US15/886,216 patent/US20180346900A1/en not_active Abandoned
-
2020
- 2020-03-18 US US16/822,764 patent/USRE49736E1/en active Active
- 2020-05-18 US US16/877,324 patent/US11046946B2/en active Active
-
2021
- 2021-06-03 US US17/338,508 patent/US12441992B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI864472B (zh) | 抗體的特異性偶聯 | |
| US12611461B2 (en) | Bioorthogonal compositions | |
| JP2021505661A5 (enExample) | ||
| Pasut et al. | PEG conjugates in clinical development or use as anticancer agents: an overview | |
| FI2451486T4 (fi) | Pegyloitu L-asparaginaasi | |
| JP2024069234A5 (enExample) | ||
| SI2451486T1 (en) | Pegylated L-asparaginase | |
| EP2477641B1 (en) | Inhibition of endosomal toll-like receptor activation for treating thrombotic disorders | |
| JP2011006428A5 (enExample) | ||
| TWI500629B (zh) | 介白素－６抗體及其用途 | |
| US8741283B2 (en) | Adenosine deaminase anticancer therapy | |
| CN108348599A (zh) | 包含金属纳米粒子、连接物及抗体的复合物 | |
| CN113874049A (zh) | 用于治疗粘膜癌的单独或与i型ifn诱导剂组合的基于壳聚糖多聚复合物的il-12的局部表达 | |
| JP2020520917A5 (enExample) | ||
| TW201922285A (zh) | 降低抗cd30抗體藥物綴合物療法之副作用之方法 | |
| CA2713571C (en) | Pharmaceutical composition or combination drug | |
| EP4644416A3 (en) | Interleukin 5 binding protein dosage regimen | |
| US20200392289A1 (en) | Biodegradable Polymer and Use Thereof | |
| RU2009122976A (ru) | Конъюгат полиэтиленгликоля-г-ксф | |
| AU2006246958A1 (en) | Triazine compounds and compositions thereof for the treatment of cancers | |
| EP3368609A1 (en) | Multifunctional biodegradable carriers for drug delivery | |
| CN112915101A (zh) | 一种抗肿瘤联合药物组合物及其应用 | |
| JP2019505493A5 (enExample) | ||
| NZ768282A (en) | Compounds including a mutant kras sequence and a lipid and uses thereof | |
| CN120550130A (zh) | 抗体-细胞偶联物、应用以及抗肿瘤的药物 |